Skip to main content

Advertisement

Log in

Guillain–Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Contactin-associated protein-like 2 (CASPR2) and leucine-rich glioma-inactivated 1 (LGI1) are essential components of the voltage-gated Kv1 potassium channel complex and are extensively expressed in both central and peripheral nervous system. Autoimmune CASPR2 and LGI1 disorders commonly present with Morvan syndrome (Mos) and/or limbic encephalitis, but whether Guillain–Barré syndrome (GBS) is a specific clinical phenotype is unknown. Here, we first reported an adult patient with dual CASPR2 and LGI1 antibodies in both serum and cerebrospinal fluid, who initially presented with a GBS-like syndrome and developed a typical MoS and respiratory paralysis, with a rapid resolution of his neurological symptoms and disappearance of autoantibodies after treatment with plasma exchange. Additionally, we also provided an overview of the previously reported GBS cases associated with CASPR2 or LGI1 antibodies. These cases expand the phenotypic spectrum of CASPR2 and LGI1 autoimmune syndromes, implying that these two antigens, especially CASPR2, are likely to participate in the etiology of GBS as a potential new target antigen, which deserves further exploration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133(9):2734–2748

    Article  Google Scholar 

  2. Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241–255

    Article  Google Scholar 

  3. Liguori R, Vincent A, Clover L et al (2001) Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124(Pt 12):2417–2426

    Article  CAS  Google Scholar 

  4. Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G (2020) Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267(4):1137–1146

    Article  Google Scholar 

  5. Fehmi J, Scherer SS, Willison HJ, Rinaldi S (2018) Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry 89(1):61–71

    Article  Google Scholar 

  6. Devaux JJ, Odaka M, Yuki N (2012) Nodal proteins are target antigens in Guillain–Barre syndrome. J Peripher Nerv Syst 17(1):62–71

    Article  CAS  Google Scholar 

  7. Rosch RE, Bamford A, Hacohen Y et al (2014) Guillain–Barre syndrome associated with CASPR2 antibodies: two paediatric cases. J Peripher Nerv Syst 19(3):246–249

    Article  CAS  Google Scholar 

  8. Tuzun E, Kinay D, Hacohen Y, Aysal F, Vincent A (2013) Guillain–Barre-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies. Muscle Nerve 48(5):836–837

    Article  Google Scholar 

  9. Lang B, Makuch M, Moloney T et al (2017) Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 88(4):353–361

    Article  Google Scholar 

  10. Tuzun E, Kurtuncu M, Lang B et al (2010) Bickerstaff’s encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 17(10):1304–1307

    Article  CAS  Google Scholar 

  11. Traka M, Goutebroze L, Denisenko N et al (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162(6):1161–1172

    Article  CAS  Google Scholar 

  12. Poliak S, Salomon D, Elhanany H et al (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162(6):1149–1160

    Article  CAS  Google Scholar 

  13. van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13(5):290–301

    Article  Google Scholar 

  14. van Sonderen A, Arino H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521–528

    Article  Google Scholar 

  15. Dalakas MC (2013) Pathophysiology of autoimmune polyneuropathies. Presse Med 42(6 Pt 2):e181-192

    Article  Google Scholar 

  16. Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ (2017) Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy. Muscle Nerve 55(4):520–525

    Article  CAS  Google Scholar 

  17. Sagane K, Ishihama Y, Sugimoto H (2008) LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11. Int J Biol Sci 4(6):387–396

    Article  CAS  Google Scholar 

  18. Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP (2009) Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 15(10):1208–1214

    Article  CAS  Google Scholar 

  19. Lotan I, Djaldetti R, Hellman MA, Benninger F (2016) Atypical case of Morvan’s syndrome. J Clin Neurosci 25:132–134

    Article  Google Scholar 

  20. Gadoth A, Pittock SJ, Dubey D et al (2017) Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol 82(1):79–92

    Article  CAS  Google Scholar 

  21. Huijbers MG, Querol LA, Niks EH et al (2015) The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 22(8):1151–1161

    Article  CAS  Google Scholar 

  22. Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82(10):879–886

    Article  CAS  Google Scholar 

  23. Koneczny I (2020) Update on IgG4-mediated autoimmune diseases: new insights and new family members. Autoimmun Rev 19(10):102646

    Article  CAS  Google Scholar 

  24. Lunemann JD, Nimmerjahn F, Dalakas MC (2015) Intravenous immunoglobulin in neurology—mode of action and clinical efficacy. Nat Rev Neurol 11(2):80–89

    Article  CAS  Google Scholar 

  25. Jiang Y, Tan C, Li T et al (2022) Phenotypic spectrum of CASPR2 and LGI1 antibodies associated neurological disorders in children. Front Pediatr 10:815976

    Article  Google Scholar 

  26. Jia Y, Shi H, Ye J, Wang Y (2020) Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies. Clin Neurol Neurosurg 197:106187

    Article  Google Scholar 

  27. Kilic MA, Yoruk Yildirim ZN, Oner A et al (2021) Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome. J Neurol 268(12):4492–4494

    Article  CAS  Google Scholar 

  28. Lancaster E, Huijbers MG, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69(2):303–311

    Article  CAS  Google Scholar 

  29. Maldonado-Slootjes S, Smetcoren C, Pieret F, Gille M (2021) An unusual association of chronic inflammatory demyelinating polyneuropathy and anti-contactin-associated protein 2 (CASPR2) syndrome. Rev Neurol (Paris) 177(4):431–433

    Article  CAS  Google Scholar 

Download references

Funding

No funding source has been used.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yang Guo.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standards

This study was approved by the local Institutional Review Board and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the patient.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 18 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, X., Liu, Y., Wu, X. et al. Guillain–Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity. J Neurol 269, 5893–5900 (2022). https://doi.org/10.1007/s00415-022-11248-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-022-11248-y

Keywords

Navigation